A study by the Indiana Chamber of Commerce highlights Indiana's ample water supply and the necessity for improved statewide water management and planning for future growth.

The NAR has revised real estate transaction rules in response to a legal verdict and $950 million penalty, impacting agent commissions and buyer-seller interactions.

A boil water advisory was issued for the Nora area in Indianapolis after a water main break, affecting about 800 customers. The advisory was lifted after 48 hours.

Lawrence Police Department hosted "Coffee with a Cop" at Panera Bread, promoting dialogue between officers and the community to enhance mutual respect and understanding.

KFD is investigating a string of fires in Kokomo, deemed suspicious, that damaged property including vehicles and a home, but no injuries were reported.

Eli Lilly surpassed Q2 expectations with strong sales from diabetes drug Mounjaro and weight loss drug Zepbound, prompting an increased full-year forecast.

Broad Ripple business owners and IMPD collaborate to improve community safety and revive nightlife, overcoming challenges from the pandemic, construction, and crime.

NASG is closing its stamping plant in Muncie, Indiana, affecting 62 workers, with no severance or continued health benefits, as part of a strategic consolidation to remain competitive.

A man was fatally shot at an Indianapolis gas station, leading to a police investigation and road closures in the area. No suspect information has been released yet.

Honest Abe Auto Sales in Indianapolis was ordered to pay almost $500,000 after the Attorney General sued for deceptive sales practices targeting those with poor credit.

Inmate Keith Martinear at Hancock County Jail is charged with intimidation and possessing dangerous devices after allegedly creating weapons in his cell.

An Indiana man, Curtis Logan Tate, was sentenced to 63 months for assaulting police during the January 6 Capitol riot with weapons and social media documentation of the acts.

Eli Lilly plans to acquire Morphic for $3.2 billion, expanding its drug portfolio with oral therapies for inflammatory bowel diseases. The deal waits for customary closing conditions.